MEDICAMEQMedicamen BiotechMEDICAMEQ info
$5.61info-1.63%24h
Global rank23197
Market cap$69.94M
Change 7d9.35%
YTD Performance-22.81%
SP500 benchmarkUnderperform
P/E0.47
P/S4.16
Revenue$16.81M
Earnings$1.76M
Dividend yield-
Main Sector
Healthcare

Medicamen Biotech (MEDICAMEQ) Stock Overview

Medicamen Biotech Limited researches, develops, manufactures, markets, sells, and distributes pharmaceutical formulations and APIs in India. The company offers a range of products, including tablets, such as non-beta lactam tablets; capsules comprising beta and non-beta lactam capsules; liquid and dry syrups; and ointments and creams. It also provides oral solid and liquid products. The company's products are used in various therapeutic areas, such as gastrointestinal, pain management, anti-infectives, pediatrics, dermatology, gynecology and rheumatology, diabetology, cardiology, oncology, and the central nervous system. Medicamen Biotech Limited was incorporated in 1993 and is based in New Delhi, India.

MEDICAMEQ Stock Information

Symbol
MEDICAMEQ
Address
1506, Chiranjiv TowerNew Delhi, 110019India
Founded
-
Trading hours
-
Website
https://medicamen.com/
Country
🇮🇳 India
Phone Number
91 11 4758 9500

Medicamen Biotech (MEDICAMEQ) Price Chart

-
Value:-

Medicamen Biotech Overview: Key Details and Summary

Stock data
2023
Change
Price
$5.61
N/A
Market Cap
$69.94M
N/A
Shares Outstanding
12.46M
1.96%
Employees
388.00
N/A
Shareholder Equity
1.93B
32.05%
Valuation
2023
Change
P/E Ratio
0.47
N/A
P/S Ratio
4.16
N/A
P/B Ratio
0.04
N/A
Growth
2023
Change
Return on Equity
0.0009
N/A
Earnings
2023
Change
Revenue
$16.81M
N/A
Earnings
$1.76M
N/A
EPS
11.82
N/A
Earnings Yield
2.11
N/A
Gross Margin
0.4882
N/A
Operating Margin
0.1243
N/A
Net income margin
0.1046
N/A
Financial Strength
2023
Change
Total Assets
$33.25M
N/A
Total Debt
$2.89M
N/A
Cash on Hand
$2.48M
N/A
Debt to Equity
0.0053
-18.65%
Cash to Debt
0.8592
479.50%
Current Ratio
$1.98
16.88%
logo
Facebook Icon
Twitter Icon
Linkedin Icon
© 2024 Topstocks.org